YYÜ GCRIS Basic veritabanının içerik oluşturulması ve kurulumu Research Ecosystems (https://www.researchecosystems.com) tarafından devam etmektedir. Bu süreçte gördüğünüz verilerde eksikler olabilir.
 

New Coagulant Agent (Ankaferd Blood Stopper) for Open Hemorrhages in Hemophilia With Inhibitor

No Thumbnail Available

Date

2010

Journal Title

Journal ISSN

Volume Title

Publisher

Sage Publications inc

Abstract

The treatment of hemophilia A patients with inhibitor could be very expensive. Ankaferd blood stopper (ABS) is a unique folkloric medicinal plant extract, which has historically been used in Turkish traditional medicine as a hemostatic agent. In this article, a 16-year-old boy was presented with uncontrolled bleeding, despite the treatment of factor VIII, rVIIa, factor VIII inhibitor bypass activity (FEIBA), cyclophosphamide, and prednisolone at circumcision site that resolved with ABS in minutes. Our patient with hemophilia A and inhibitor is the first clinical pediatric case.

Description

Sal, Ertan/0000-0003-2761-2675

Keywords

Ankaferd Blood Stopper, Hemophilia A, Inhibitor

Turkish CoHE Thesis Center URL

WoS Q

Q2

Scopus Q

Q2

Source

Volume

16

Issue

6

Start Page

705

End Page

707